{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:26:08Z","timestamp":1793651168337,"version":"4.5.1"},"reference-count":215,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary and Animal Science"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.vas.2026.100883","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:26:47Z","timestamp":1790486807000},"page":"100883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Advances and challenges in avian influenza vaccines: From conventional approaches to next-generation strategies"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2232-4121","authenticated-orcid":false,"given":"Mahboobeh","family":"Nazari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mahdi","family":"Mehrazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.vas.2026.100883_bib0001","article-title":"Toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1)","volume":"14","year":"2008","journal-title":"Emerging Infectious Diseases"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0002","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.virol.2006.10.037","article-title":"Characterization of avian H9N2 influenza viruses from United Arab Emirates 2000 to 2003","volume":"361","author":"Aamir","year":"2007","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vas.2026.100883_bib0003","first-page":"165","article-title":"The combined use of rHVT-H5 and rHVT-F vector vaccines in the hatchery enhances immunity against highly pathogenic avian influenza H5N1 and velogenic Newcastle disease viral infections in commercial chickens","volume":"6","author":"Abd El-Hamid","year":"2018","journal-title":"Poultry Science Journal"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0004","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.vetmic.2011.08.004","article-title":"Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against Egyptian highly pathogenic avian influenza H5N1","volume":"155","author":"Abdelwhab","year":"2012","journal-title":"Veterinary Microbiology"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11259-025-10919-1","article-title":"Investigation into the efficacy of a commercially available inactivated avian influenza virus (AIV) vaccine (H9N2) through experimental and field assessments, with an emphasis on its compatibility with recent AIV (H9N2) G1-sublineage isolates","volume":"50","author":"Abdullatif","year":"2026","journal-title":"Veterinary Research Communications"},{"issue":"3","key":"10.1016\/j.vas.2026.100883_bib0006","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s13337-020-00593-z","article-title":"Human infection with Avian influenza A virus in Nepal: Requisite for timely management and preparedness","volume":"31","author":"Acharya","year":"2020","journal-title":"VirusDisease"},{"issue":"3","key":"10.1016\/j.vas.2026.100883_bib0007","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1017\/S0043933909000385","article-title":"Economic impact assessment of highly pathogenic avian influenza on the poultry industry in Ghana","volume":"65","author":"Akunzule","year":"2009","journal-title":"World's Poultry Science Journal"},{"issue":"10","key":"10.1016\/j.vas.2026.100883_bib0008","article-title":"Avian influenza overview June-September 2024","volume":"22","author":"Alexakis","year":"2024","journal-title":"EFSA Journal"},{"issue":"30","key":"10.1016\/j.vas.2026.100883_bib0009","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1016\/j.vaccine.2006.10.051","article-title":"An overview of the epidemiology of avian influenza","volume":"25","author":"Alexander","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vas.2026.100883_bib0010","doi-asserted-by":"crossref","DOI":"10.1007\/s42452-026-09228-2","article-title":"Mapping the evolution of the research landscape of artificial intelligence and machine learning in veterinary and animal sciences","author":"Ali","year":"2026","journal-title":"Discover Applied Sciences"},{"issue":"4","key":"10.1016\/j.vas.2026.100883_bib0011","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/hgtb.2015.020","article-title":"Skin transfection patterns and expression kinetics of electroporation-enhanced plasmid delivery using the CELLECTRA-3P, a portable next-generation dermal electroporation device","volume":"26","author":"Amante","year":"2015","journal-title":"Human Gene Therapy Methods"},{"issue":"3","key":"10.1016\/j.vas.2026.100883_bib0012","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/ISB-00230","article-title":"In silico analysis of genes nucleoprotein, neuraminidase and hemagglutinin: A comparative study on different strains of influenza A (Bird Flu) virus sub-type H5N1","volume":"6","author":"Anwar","year":"2006","journal-title":"In Silico Biology"},{"issue":"12","key":"10.1016\/j.vas.2026.100883_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/v15122355","article-title":"Low pathogenic Avian influenza H9N2 viruses in Morocco: Antigenic and molecular evolution from 2021 to 2023","volume":"15","author":"Arbani","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.vas.2026.100883_bib0014","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-3-540-92165-3_16","article-title":"Adjuvants for pandemic influenza vaccines","author":"Atmar","year":"2009","journal-title":"Vaccines for Pandemic Influenza"},{"issue":"4","key":"10.1016\/j.vas.2026.100883_bib0015","article-title":"Pichia pastoris an ideal host for the production of recombinant Influenza vaccines","volume":"18","author":"Baghkheirati","year":"2024","journal-title":"Iranian Journal of Veterinary Medicine"},{"key":"10.1016\/j.vas.2026.100883_bib0016","series-title":"Avian diseases","article-title":"Antigenic and genetic diversity of highly pathogenic avian influenza a (H5N1) viruses isolated in Egypt","author":"Balish","year":"2010"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0017","first-page":"77","article-title":"Control of highly pathogenic avian influenza by evidence-based vaccinology: Past progress, future prospect","volume":"15","author":"Baradaran","year":"2019","journal-title":"Iranian Journal of Epidemiology"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0018","first-page":"21","article-title":"Developing cell culture-derived pandemic vaccines","volume":"12","author":"Barrett","year":"2010","journal-title":"Current Opinion in Molecular Therapeutics"},{"key":"10.1016\/j.vas.2026.100883_bib0019","doi-asserted-by":"crossref","first-page":"S405","DOI":"10.1093\/infdis\/jiab269","article-title":"Influenza vaccines: Successes and continuing challenges","volume":"224","author":"Becker","year":"2021","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1016\/j.vas.2026.100883_bib0020","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3201\/eid1506.090072","article-title":"Past, present, and possible future human infection with influenza virus A subtype H7","volume":"15","author":"Belser","year":"2009","journal-title":"Emerging Infectious Diseases"},{"issue":"40","key":"10.1016\/j.vas.2026.100883_bib0021","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1016\/j.vaccine.2009.07.005","article-title":"Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery","volume":"27","author":"Best","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vas.2026.100883_bib0022","series-title":"Glycoscience: Biology and medicine","first-page":"1","article-title":"Influenza virus, overview: Structures, infection mechanisms and antivirals","author":"B\u00f6hm","year":"2014"},{"issue":"21","key":"10.1016\/j.vas.2026.100883_bib0023","doi-asserted-by":"crossref","first-page":"12339","DOI":"10.1128\/JVI.02142-14","volume":"88","author":"Broadbent","year":"2014","journal-title":"Journal of Virology"},{"key":"10.1016\/j.vas.2026.100883_bib0024","first-page":"23","article-title":"International standards and guidelines for vaccination of poultry against highly pathogenic avian influenza","volume":"130","author":"Bruschke","year":"2007","journal-title":"Developments In Biologicals"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1196\/annals.1373.023","article-title":"Development and use of fowlpox vectored vaccines for avian influenza","volume":"1081","author":"Bublot","year":"2006","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"7","key":"10.1016\/j.vas.2026.100883_bib0026","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3390\/ijms18071541","article-title":"The interplay between the host receptor and influenza virus hemagglutinin and neuraminidase","volume":"18","author":"Byrd-Leotis","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0027","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/10717544.2018.1450909","article-title":"Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet\u2122 or in vivo-jetPEI\u00ae induces enhanced serological, cellular and protective immune responses","volume":"25","author":"Cao","year":"2018","journal-title":"Drug Delivery"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0028","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/0307945021000070714","article-title":"Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza","volume":"32","author":"Capua","year":"2003","journal-title":"Avian Pathology"},{"key":"10.1016\/j.vas.2026.100883_bib0029","first-page":"137","article-title":"Diagnosing avian influenza infection in vaccinated populations by systems for differentiating infected from vaccinated animals (DIVA)","volume":"130","author":"Capua","year":"2007","journal-title":"Developments In Biologicals"},{"key":"10.1016\/j.vas.2026.100883_bib0030","first-page":"135","article-title":"Diagnosing avian influenza infection in vaccinated populations by systems for differentiating infected from vaccinated animals (DIVA)","volume":"130","author":"Capua","year":"2007","journal-title":"Developments in Biologicals"},{"key":"10.1016\/j.vas.2026.100883_bib0031","first-page":"229","article-title":"DIVA\u2013a vaccination strategy enabling the detection of field exposure to avian influenza","volume":"119","author":"Capua","year":"2004","journal-title":"Developments In Biologicals"},{"key":"10.1016\/j.vas.2026.100883_bib0032","series-title":"Developments in biologicals","article-title":"DIVA - A vaccination strategy enabling the detection of field exposure to avian influenza","author":"Capua","year":"2005"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0033","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41541-024-00923-y","article-title":"Mass vaccination with reassortment-impaired live H9N2 avian influenza vaccine","volume":"9","author":"Cargnin Faccin","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"17","key":"10.1016\/j.vas.2026.100883_bib0034","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1128\/JVI.02403-10","article-title":"Antigenic drift in H5N1 avian influenza virus in poultry is driven by mutations in major antigenic sites of the hemagglutinin molecule analogous to those for human influenza virus","volume":"85","author":"Cattoli","year":"2011","journal-title":"Journal of Virology"},{"key":"10.1016\/j.vas.2026.100883_bib0035","first-page":"189","article-title":"Plant-produced avian influenza antigens","author":"Ceballo","year":"2018","journal-title":"Prospects of Plant-Based Vaccines in Veterinary Medicine"},{"issue":"11","key":"10.1016\/j.vas.2026.100883_bib0036","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines13111164","article-title":"Brief comparison of novel influenza vaccine design strategies","volume":"13","author":"Chai","year":"2025","journal-title":"Vaccines"},{"issue":"Suppl 2","key":"10.1016\/j.vas.2026.100883_bib0037","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1086\/338820","article-title":"Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997","volume":"34","author":"Chan","year":"2002","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.vas.2026.100883_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126883","article-title":"sa-mRNA influenza vaccine raises a higher and more durable immune response than mRNA vaccine in preclinical models","volume":"51","author":"Chang","year":"2025","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vas.2026.100883_bib0039","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.procbio.2011.02.019","article-title":"Production of immunogenic one-component avian H7-subtype influenza virus-like particles","volume":"46","author":"Chang","year":"2011","journal-title":"Process Biochemistry"},{"issue":"9","key":"10.1016\/j.vas.2026.100883_bib0040","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/dna.2009.0977","article-title":"Comparison of adjuvant efficacy of chitosan and aluminum hydroxide for intraperitoneally administered inactivated influenza H5N1 vaccine","volume":"29","author":"Chang","year":"2010","journal-title":"DNA and Cell Biology"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0041","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01627-18","article-title":"Amino acid residue 217 in the hemagglutinin glycoprotein is a key mediator of avian influenza H7N9 virus antigenicity","volume":"93","author":"Chang","year":"2019","journal-title":"Journal of Virology"},{"key":"10.1016\/j.vas.2026.100883_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.138405","article-title":"Self-assembling nanoparticle vaccine elicits a robust protective immune response against avian influenza H5N6 virus in chickens","volume":"287","author":"Chen","year":"2025","journal-title":"International Journal of Biological Macromolecules"},{"issue":"8","key":"10.1016\/j.vas.2026.100883_bib0043","article-title":"Addition of \u03b1Gal HyperAcute\u2122 technology to recombinant avian influenza vaccines induces strong low-dose antibody responses","volume":"12","author":"Chen","year":"2017","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.vas.2026.100883_bib0044","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3390\/vaccines12121382","article-title":"Advantages of broad-spectrum influenza mRNA vaccines and their impact on pulmonary influenza","volume":"12","author":"Cheng","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.vas.2026.100883_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.769088","article-title":"Epigallocatechin-3-gallate as a novel vaccine adjuvant","volume":"12","author":"Cheong","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"13","key":"10.1016\/j.vas.2026.100883_bib0046","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.vaccine.2018.09.034","article-title":"Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development","volume":"37","author":"Chia","year":"2019","journal-title":"Vaccine"},{"issue":"2\u20134","key":"10.1016\/j.vas.2026.100883_bib0047","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.vetmic.2012.11.035","article-title":"Protective efficacy of baculovirus-derived influenza virus-like particles bearing H5 HA alone or in combination with M1 in chickens","volume":"162","author":"Choi","year":"2013","journal-title":"Veterinary Microbiology"},{"issue":"10","key":"10.1016\/j.vas.2026.100883_bib0048","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.4161\/rna.22081","article-title":"Specific temperature-induced perturbations of secondary mRNA structures are associated with the cold-adapted temperature-sensitive phenotype of influenza A virus","volume":"9","author":"Chursov","year":"2012","journal-title":"RNA Biology"},{"issue":"4","key":"10.1016\/j.vas.2026.100883_bib0049","first-page":"399","article-title":"Broad-range neutralizing anti-influenza a human monoclonal antibodies: New perspectives in therapy and prophylaxis","volume":"35","author":"Clementi","year":"2012","journal-title":"New Microbiologica"},{"issue":"5","key":"10.1016\/j.vas.2026.100883_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010645","article-title":"A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1","volume":"5","author":"Cornelissen","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0051","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1750-2659.2006.00007.x","article-title":"Production of a novel influenza vaccine using insect cells: Protection against drifted strains","volume":"1","author":"Cox","year":"2007","journal-title":"Influenza And Other Respiratory Viruses"},{"issue":"18","key":"10.1016\/j.vas.2026.100883_bib0052","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.vaccine.2023.03.055","article-title":"Efficacy of multivalent recombinant herpesvirus of turkey vaccines against high pathogenicity avian influenza, infectious bursal disease, and Newcastle disease viruses","volume":"41","author":"Criado","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vas.2026.100883_bib0053","series-title":"Avian influenza virus: Prevalence infection and therapy, in viral, parasitic, bacterial, and fungal infections","first-page":"141","author":"Debnath","year":"2023"},{"key":"10.1016\/j.vas.2026.100883_bib0054","first-page":"151","article-title":"Inactivated and adjuvanted influenza vaccines","author":"Del Giudice","year":"2014","journal-title":"Influenza Pathogenesis and Control-Volume II"},{"issue":"3","key":"10.1016\/j.vas.2026.100883_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11030593","article-title":"Immune control of Avian Influenza virus infection and its vaccine development","volume":"11","author":"Dey","year":"2023","journal-title":"Vaccines"},{"issue":"6","key":"10.1016\/j.vas.2026.100883_bib0056","article-title":"Evolutionary and mutational characterization of the first H5N8 subtype Influenza A virus in humans","volume":"11","author":"Ding","year":"2022","journal-title":"Pathogens (Basel, Switzerland)"},{"issue":"2","key":"10.1016\/j.vas.2026.100883_bib0057","doi-asserted-by":"crossref","DOI":"10.1093\/immhor\/vlae007","article-title":"Combination adjuvant improves influenza virus immunity by downregulation of immune homeostasis genes in lymphocytes","volume":"9","author":"Dollinger","year":"2025","journal-title":"ImmunoHorizons"},{"key":"10.1016\/j.vas.2026.100883_bib0058","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2025.1394675","article-title":"Research publications and global manufacture of veterinary vaccines against avian influenza A (2019-2023)","volume":"12","author":"Dom\u00ednguez-Odio","year":"2025","journal-title":"Frontiers in Veterinary Science"},{"issue":"4","key":"10.1016\/j.vas.2026.100883_bib0059","first-page":"634","article-title":"Influenza virus A H5N1 and H1N1: Features and zoonotic potential","volume":"24","author":"Echeverry","year":"2011","journal-title":"Revista Colombiana de Ciencias Pecuarias"},{"issue":"2","key":"10.1016\/j.vas.2026.100883_bib0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.14202\/vetworld.2017.187-193","article-title":"Preparation of mucosal nanoparticles and polymer-based inactivated vaccine for Newcastle disease and H9N2 AI viruses","volume":"10","author":"El Naggar","year":"2017","journal-title":"Veterinary World"},{"issue":"36","key":"10.1016\/j.vas.2026.100883_bib0061","doi-asserted-by":"crossref","first-page":"13133","DOI":"10.1073\/pnas.1414070111","article-title":"Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans","volume":"111","author":"Ellebedy","year":"2014","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"36","key":"10.1016\/j.vas.2026.100883_bib0062","doi-asserted-by":"crossref","first-page":"13133","DOI":"10.1073\/pnas.1414070111","article-title":"Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans","volume":"111","author":"Ellebedy","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"10.1016\/j.vas.2026.100883_bib0063","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1586\/erv.10.123","article-title":"Cross-protective immunity to influenza A viruses","volume":"9","author":"Epstein","year":"2010","journal-title":"Expert Review of Vaccines"},{"issue":"6","key":"10.1016\/j.vas.2026.100883_bib0064","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/v16060829","article-title":"Development of a fully protective pandemic avian influenza subunit vaccine in insect pupae","volume":"16","author":"Falc\u00f3n","year":"2024","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.vas.2026.100883_bib0065","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2225645","article-title":"Genetic characterization of a new candidate hemagglutinin subtype of influenza A viruses","volume":"12","author":"Fereidouni","year":"2023","journal-title":"Emerging Microbes & Infections"},{"issue":"6930","key":"10.1016\/j.vas.2026.100883_bib0066","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature01509","article-title":"Ecological and immunological determinants of influenza evolution","volume":"422","author":"Ferguson","year":"2003","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.vas.2026.100883_bib0067","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00705-017-3230-7","article-title":"Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus","volume":"162","author":"Fotouhi","year":"2017","journal-title":"Archives of Virology"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0068","doi-asserted-by":"crossref","first-page":"319","DOI":"10.20506\/rst.28.1.1862","article-title":"Novel avian influenza virus vaccines","volume":"28","author":"Fuchs","year":"2009","journal-title":"OIE Revue Scientifique et Technique"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0069","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1038\/s41467-024-48555-z","article-title":"Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus","volume":"15","author":"Furey","year":"2024","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/j.vas.2026.100883_bib0070","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.biologicals.2014.12.003","article-title":"Introduction of an update system for vaccine strains of veterinary influenza vaccines in Japan","volume":"43","author":"Gamoh","year":"2015","journal-title":"Biologicals: Journal of the International Association of Biological Standardization"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0071","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/vaccines8010065","article-title":"miRNA targeted NP genome of live attenuated influenza vaccines provide cross-protection against a lethal influenza virus infection","volume":"8","author":"Gao","year":"2020","journal-title":"Vaccines"},{"issue":"10","key":"10.1016\/j.vas.2026.100883_bib0072","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3390\/vaccines10101683","article-title":"AddaVax-adjuvanted H5N8 inactivated vaccine induces robust humoral immune response against different clades of H5 viruses","volume":"10","author":"Gao","year":"2022","journal-title":"Vaccines"},{"issue":"11","key":"10.1016\/j.vas.2026.100883_bib0073","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.vaccine.2023.01.018","article-title":"Development of in ovo-compatible NS1-truncated live attenuated influenza vaccines by modulation of hemagglutinin cleavage and polymerase acidic X frameshifting sites","volume":"41","author":"Ghorbani","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vas.2026.100883_bib0074","article-title":"Investigation of risk factors for introduction of highly pathogenic avian influenza H5N1 virus onto table egg farms in the United States, 2022: A case-control study","volume":"10","author":"Green","year":"2023","journal-title":"The Journal of Veterinary Science"},{"issue":"26","key":"10.1016\/j.vas.2026.100883_bib0075","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1016\/j.vaccine.2008.03.076","article-title":"A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines","volume":"26","author":"Gregersen","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vas.2026.100883_bib0076","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/v14040730","article-title":"Characterization of immune response towards generation of universal anti-HA-stalk antibodies after immunization of broiler hens with triple H5N1\/NA-HA-M1 VLPs","volume":"14","author":"Gromadzka","year":"2022","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.vas.2026.100883_bib0077","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/v14040730","article-title":"Characterization of immune response towards generation of universal anti-HA-stalk antibodies after immunization of broiler hens with triple H5N1\/NA-HA-M1 VLPs","volume":"14","author":"Gromadzka","year":"2022","journal-title":"Viruses"},{"issue":"16","key":"10.1016\/j.vas.2026.100883_bib0078","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1073\/pnas.96.16.9363","article-title":"Molecular characterization of H9N2 influenza viruses: Were they the donors of the \"internal\" genes of H5N1 viruses in Hong Kong?","volume":"96","author":"Guan","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0079","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038455","article-title":"Antivirals targeting the neuraminidase","volume":"12","author":"Gubareva","year":"2022","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"14","key":"10.1016\/j.vas.2026.100883_bib0080","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1128\/JVI.00609-11","article-title":"A reassortment-incompetent live attenuated influenza virus vaccine for protection against pandemic virus strains","volume":"85","author":"Hai","year":"2011","journal-title":"Journal of Virology"},{"issue":"3","key":"10.1016\/j.vas.2026.100883_bib0081","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1128\/JVI.02949-14","article-title":"Biological and protective properties of immune sera directed to the influenza virus neuraminidase","volume":"89","author":"Halbherr","year":"2015","journal-title":"Journal of Virology"},{"issue":"9","key":"10.1016\/j.vas.2026.100883_bib0082","first-page":"1567","article-title":"[The latest trend and prospects of development of influenza vaccine]","volume":"69","author":"Harada","year":"2011","journal-title":"Nihon Rinsho. Japanese journal of clinical medicine"},{"issue":"4","key":"10.1016\/j.vas.2026.100883_bib0083","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/vim.2015.0127","article-title":"Avian influenza virus and DIVA strategies","volume":"29","author":"Hasan","year":"2016","journal-title":"Viral Immunology"},{"issue":"778","key":"10.1016\/j.vas.2026.100883_bib0084","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ads1273","article-title":"An influenza mRNA vaccine protects ferrets from lethal infection with highly pathogenic avian influenza A (H5N1) virus","volume":"16","author":"Hatta","year":"2024","journal-title":"Science Translational Medicine"},{"issue":"2","key":"10.1016\/j.vas.2026.100883_bib0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1586\/14760584.2016.1115352","article-title":"Strategies towards universal pandemic influenza vaccines","volume":"15","author":"He","year":"2016","journal-title":"Expert Review of Vaccines"},{"issue":"3","key":"10.1016\/j.vas.2026.100883_bib0086","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060413","article-title":"Molecular basis of live-attenuated influenza virus","volume":"8","author":"He","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vas.2026.100883_bib0087","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2019.02.004","article-title":"Highly immunogenic influenza virus-like particles containing B-cell-activating factor (BAFF) for multi-subtype vaccine development","volume":"164","author":"Hong","year":"2019","journal-title":"Antiviral Research"},{"key":"10.1016\/j.vas.2026.100883_bib0088","doi-asserted-by":"crossref","unstructured":"Howard, M.K., O. Kistner, and P.N. Barrett, Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines. 2008.","DOI":"10.1515\/BC.2008.060"},{"issue":"45","key":"10.1016\/j.vas.2026.100883_bib0089","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1016\/j.vaccine.2008.08.015","article-title":"Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines","volume":"26","author":"Hu","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vas.2026.100883_bib0090","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1186\/1471-2105-12-S1-S31","article-title":"Changed epitopes drive the antigenic drift for influenza A (H3N2) viruses","volume":"12","author":"Huang","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.vas.2026.100883_bib0091","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1766957","article-title":"Advances and prospects of mucosal vaccination in the prevention and control of avian influenza","volume":"17","author":"Hui","year":"2026","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"10.1016\/j.vas.2026.100883_bib0092","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.virol.2011.01.004","article-title":"Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A\/Leningrad\/134\/17\/57 (H2N2)","volume":"412","author":"Isakova-Sivak","year":"2011","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vas.2026.100883_bib0093","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s13337-018-0463-3","article-title":"Prime-boost vaccination strategy against avian influenza and Newcastle disease viruses reduces shedding of the challenge viruses","volume":"29","author":"Ismail","year":"2018","journal-title":"Virusdisease"},{"key":"10.1016\/j.vas.2026.100883_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2025.105257","article-title":"Naringenin as a phytogenic adjuvant systematically enhances the protective efficacy of H9N2 inactivated vaccine through coordinated innate-adaptive immune priming in chickens","author":"Jiao","year":"2025","journal-title":"Poultry Science"},{"issue":"16","key":"10.1016\/j.vas.2026.100883_bib0095","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1016\/j.vaccine.2007.01.030","article-title":"Changing perspective on immunization against influenza","volume":"25","author":"Johansson","year":"2007","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vas.2026.100883_bib0096","doi-asserted-by":"crossref","first-page":"13556","DOI":"10.1128\/JVI.02244-13","article-title":"Truncation and sequence shuffling of segment 6 generate replication-competent neuraminidase-negative influenza H5N1 viruses","volume":"87","author":"Kalthoff","year":"2013","journal-title":"Journal of Virology"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0097","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1038\/s41467-023-38415-7","article-title":"Rapid evolution of A(H5N1) influenza viruses after intercontinental spread to North America","volume":"14","author":"Kandeil","year":"2023","journal-title":"Nature Communications"},{"key":"10.1016\/j.vas.2026.100883_bib0098","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-3-540-92165-3_14","article-title":"Influenza virus-like particles as pandemic vaccines","author":"Kang","year":"2009","journal-title":"Vaccines for Pandemic Influenza"},{"issue":"1\u20132","key":"10.1016\/j.vas.2026.100883_bib0099","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.virusres.2011.09.037","article-title":"Novel vaccines against influenza viruses","volume":"162","author":"Kang","year":"2011","journal-title":"Virus Research"},{"issue":"3","key":"10.1016\/j.vas.2026.100883_bib0100","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3201\/eid2203.150593","article-title":"Avian influenza a(H5N1) virus in Egypt","volume":"22","author":"Kayali","year":"2016","journal-title":"Emerging Infectious Diseases"},{"issue":"12","key":"10.1016\/j.vas.2026.100883_bib0101","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1016\/j.vaccine.2011.01.055","article-title":"Stability of RNA virus attenuation approaches","volume":"29","author":"Kenney","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vas.2026.100883_bib0102","article-title":"Adenoviral vectors as vaccines for emerging Avian influenza viruses","volume":"11","author":"Kerstetter","year":"2020","journal-title":"Frontiers in Immunology"},{"issue":"24","key":"10.1016\/j.vas.2026.100883_bib0103","doi-asserted-by":"crossref","first-page":"11044","DOI":"10.1073\/pnas.1006419107","article-title":"Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry","volume":"107","author":"Kim","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0104","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/1471-2334-10-236","article-title":"Multi-agent modeling of the South Korean avian influenza epidemic","volume":"10","author":"Kim","year":"2010","journal-title":"BMC Infectious Diseases"},{"issue":"4","key":"10.1016\/j.vas.2026.100883_bib0105","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3103\/S0891416811040045","article-title":"Genome composition analysis of reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine","volume":"26","author":"Kiseleva","year":"2011","journal-title":"Molecular Genetics, Microbiology and Virology"},{"issue":"32","key":"10.1016\/j.vas.2026.100883_bib0106","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1016\/j.vaccine.2007.05.013","article-title":"Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses","volume":"25","author":"Kistner","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vas.2026.100883_bib0107","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines13050453","article-title":"Avian Influenza Clade 2.3.4.4b: Global impact and summary analysis of vaccine trials","volume":"13","author":"Kov\u00e1cs","year":"2025","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.vas.2026.100883_bib0108","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.AID-0021-2014","article-title":"Committing the oldest sins in the newest kind of ways\u2014Antibodies targeting the influenza virus type A hemagglutinin globular head","volume":"2","author":"Krause","year":"2014","journal-title":"Microbiology Spectrum"},{"issue":"9","key":"10.1016\/j.vas.2026.100883_bib0109","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1128\/JVI.02335-08","article-title":"Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus","volume":"83","author":"Laddy","year":"2009","journal-title":"Journal of Virology"},{"issue":"21","key":"10.1016\/j.vas.2026.100883_bib0110","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1016\/j.vaccine.2010.03.029","article-title":"Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing","volume":"28","author":"Le Ru","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1079\/AHR2005101","article-title":"Avian influenza virus: Prospects for prevention and control by vaccination","volume":"6","author":"Lee","year":"2005","journal-title":"Animal Health Research Reviews"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1079\/AHR2005101","article-title":"Avian influenza virus: Prospects for prevention and control by vaccination","volume":"6","author":"Lee","year":"2005","journal-title":"Animal Health Research Reviews \/Conference of Research Workers in Animal Diseases"},{"issue":"S1","key":"10.1016\/j.vas.2026.100883_bib0113","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4142\/jvs.2017.18.S1.269","article-title":"Evolution, global spread, and pathogenicity of highly pathogenic avian influenza H5Nx clade 2.3.4.4","volume":"18","author":"Lee","year":"2017","journal-title":"The Journal of Veterinary Science"},{"issue":"8","key":"10.1016\/j.vas.2026.100883_bib0114","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00795-25","article-title":"Development of DNA and mRNA-LNP vaccines against an H5N1 clade 2.3. 4.4 b influenza virus","volume":"99","author":"Leonard","year":"2025","journal-title":"Journal of Virology"},{"issue":"39","key":"10.1016\/j.vas.2026.100883_bib0115","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1016\/j.vaccine.2010.12.057","article-title":"A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle","volume":"29","author":"Lin","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vas.2026.100883_bib0116","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/hgtb.2011.209","article-title":"Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device","volume":"23","author":"Lin","year":"2012","journal-title":"Human Gene Therapy, Part B: Methods"},{"issue":"17","key":"10.1016\/j.vas.2026.100883_bib0117","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00547-18","article-title":"Structural basis for the broad, antibody-mediated neutralization of H5N1 influenza virus","volume":"92","author":"Lin","year":"2018","journal-title":"Journal Of Virology"},{"key":"10.1016\/j.vas.2026.100883_bib0118","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2016.07.021","article-title":"Multi-subtype influenza virus-like particles incorporated with flagellin and granulocyte-macrophage colony-stimulating factor for vaccine design","volume":"133","author":"Liu","year":"2016","journal-title":"Antiviral Research"},{"issue":"4","key":"10.1016\/j.vas.2026.100883_bib0119","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.3390\/ijms25042132","article-title":"Polysaccharide from atractylodes macrocephala koidz binding with zinc oxide nanoparticles as a novel mucosal immune adjuvant for H9N2 inactivated vaccine","volume":"25","author":"Liu","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/j.vas.2026.100883_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2024.103496","article-title":"Mucosal immune responses and protective efficacy elicited by oral administration AMP-ZnONPs-adjuvanted inactivated H9N2 virus in chickens","volume":"103","author":"Liu","year":"2024","journal-title":"Poultry Science"},{"issue":"4","key":"10.1016\/j.vas.2026.100883_bib0121","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.vaccine.2009.10.111","article-title":"Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques","volume":"28","author":"Livingston","year":"2010","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.vas.2026.100883_bib0122","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1016\/j.vaccine.2017.05.010","article-title":"Immunologic evaluation of 10 different adjuvants for use in vaccines for chickens against highly pathogenic avian influenza virus","volume":"35","author":"Lone","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vas.2026.100883_bib0123","first-page":"13","article-title":"Control strategies for highly pathogenic avian influenza: A global perspective","volume":"130","author":"Lubroth","year":"2007","journal-title":"Developments in Biologicals"},{"key":"10.1016\/j.vas.2026.100883_bib0124","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2024.110264","article-title":"Enhancement of protective efficacy of recombinant attenuated Salmonella typhimurium delivering H9N2 avian influenza virus hemagglutinins (HA) antigen vaccine candidate strains by CC motif chemokine ligand 5 in chickens (chCCL5)","volume":"298","author":"Ma","year":"2024","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.vas.2026.100883_bib0125","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1053872","article-title":"Manganese-based nanoadjuvants for enhancement of immune effect of DNA vaccines","volume":"10","author":"Ma","year":"2022","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"8","key":"10.1016\/j.vas.2026.100883_bib0126","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.vaccine.2010.12.046","article-title":"Enhancement of immunogenicity of a virosome-based avian influenza vaccine in chickens by incorporating CpG-ODN","volume":"29","author":"Mallick","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vas.2026.100883_bib0127","first-page":"226","article-title":"Vaccination with CpG-adjuvanted avian influenza virosomes promotes antiviral immune responses and reduces virus shedding in chickens","volume":"25","author":"Mallick","year":"2012","journal-title":"Viral Immunology"},{"key":"10.1016\/j.vas.2026.100883_bib0128","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3389\/fvets.2020.00647","article-title":"Influenza A virus in Swine: Epidemiology, challenges and vaccination strategies","volume":"7","author":"Mancera Gracia","year":"2020","journal-title":"Frontiers in Veterinary Science"},{"key":"10.1016\/j.vas.2026.100883_bib0129","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines5030018","article-title":"Egg-independent influenza vaccines and vaccine candidates","volume":"5","author":"Manini","year":"2017","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1863-2378.2007.01086.x","article-title":"Use of vaccination in avian influenza control and eradication","volume":"55","author":"Marangon","year":"2008","journal-title":"Zoonoses And Public Health"},{"key":"10.1016\/j.vas.2026.100883_bib0131","first-page":"99","article-title":"Planning and executing a vaccination campaign against avian influenza","volume":"130","author":"Marangon","year":"2007","journal-title":"Developments In Biologicals"},{"issue":"12","key":"10.1016\/j.vas.2026.100883_bib0132","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2174\/1381612824666180309125344","article-title":"Plant-produced recombinant influenza A vaccines based on the M2e peptide","volume":"24","author":"Mardanova","year":"2018","journal-title":"Current Pharmaceutical Design"},{"issue":"7","key":"10.1016\/j.vas.2026.100883_bib0133","doi-asserted-by":"crossref","DOI":"10.5455\/OVJ.2025.v15.i7.4","article-title":"The biology of the avian influenza virus: A comprehensive review with insights into novel therapeutic strategies","volume":"15","author":"Mekkawy","year":"2025","journal-title":"Open Veterinary Journal"},{"issue":"38","key":"10.1016\/j.vas.2026.100883_bib0134","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1016\/j.vaccine.2023.07.076","article-title":"Prediction of highly pathogenic avian influenza vaccine efficacy in chickens by comparison of in vitro and in vivo data: A meta-analysis and systematic review","volume":"41","author":"Mo","year":"2023","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vas.2026.100883_bib0135","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00493-21","article-title":"Development of a genetically stable live attenuated influenza vaccine strain using an engineered high-fidelity viral polymerase","volume":"95","author":"Mori","year":"2021","journal-title":"Journal of Virology"},{"issue":"6","key":"10.1016\/j.vas.2026.100883_bib0136","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/femsre\/fuz019","article-title":"Global patterns of avian influenza A (H7): Virus evolution and zoonotic threats","volume":"43","author":"Naguib","year":"2019","journal-title":"FEMS Microbiology Reviews"},{"issue":"4","key":"10.1016\/j.vas.2026.100883_bib0137","first-page":"319","article-title":"Immunogenicity of concentrated and purified inactivated avian influenza vaccine formulation","volume":"73","author":"Nazari","year":"2018","journal-title":"Archives of Razi Institute"},{"issue":"8","key":"10.1016\/j.vas.2026.100883_bib0138","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1208\/s12249-021-02145-0","article-title":"AddaVax formulated with PolyI: C as a potential adjuvant of MDCK-based influenza vaccine enhances local, cellular, and antibody protective immune response in mice","volume":"22","author":"Nian","year":"2021","journal-title":"Aaps Pharmscitech"},{"issue":"9","key":"10.1016\/j.vas.2026.100883_bib0139","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9091032","article-title":"An overview of influenza viruses and vaccines","volume":"9","author":"Nuwarda","year":"2021","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.vas.2026.100883_bib0140","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/v11040321","article-title":"Subclade 2.2. 1-specific human monoclonal antibodies that recognize an epitope in antigenic site A of influenza A (H5) virus HA detected between 2015 and 2018","volume":"11","author":"Okuda","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vas.2026.100883_bib0141","doi-asserted-by":"crossref","unstructured":"Oyekale, A. and B. Shittu, Assessment of poultry products supply and market prices during Avian Influenza outbreak in Nigeria evidence from Osun State. 2012.","DOI":"10.3923\/javaa.2012.3618.3622"},{"issue":"6","key":"10.1016\/j.vas.2026.100883_bib0142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039921","article-title":"Sublingual immunization with a live attenuated influenza a virus lacking the nonstructural protein 1 induces broad protective immunity in mice","volume":"7","author":"Park","year":"2012","journal-title":"PloS one"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0143","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41598-018-36426-9","article-title":"Adjuvanted influenza vaccine dynamics","volume":"9","author":"Parra-Rojas","year":"2019","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/j.vas.2026.100883_bib0144","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11262-020-01765-1","article-title":"Genetic and antigenic characterization of influenza A\/H5N1 viruses isolated from patients in Indonesia, 2008\u20132015","volume":"56","author":"Pawestri","year":"2020","journal-title":"Virus Genes"},{"issue":"6","key":"10.1016\/j.vas.2026.100883_bib0145","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.vaccine.2013.12.005","article-title":"Inferring the antigenic epitopes for highly pathogenic avian influenza H5N1 viruses","volume":"32","author":"Peng","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vas.2026.100883_bib0146","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nbt.1542","article-title":"MicroRNA-mediated species-specific attenuation of influenza A virus","volume":"27","author":"Perez","year":"2009","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.vas.2026.100883_bib0147","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1080\/21645515.2019.1701912","article-title":"Quadrivalent cell culture influenza virus vaccine. comparison to egg-derived vaccine","author":"P\u00e9rez-Rubio","year":"2020","journal-title":"Human Vaccines and Immunotherapeutics"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268808001039","article-title":"Avian influenza vaccines: A practical review in relation to their application in the field with a focus on the Asian experience","volume":"137","author":"Peyre","year":"2009","journal-title":"Epidemiology & Infection"},{"key":"10.1016\/j.vas.2026.100883_bib0149","series-title":"Replicating vaccines","first-page":"195","article-title":"Live attenuated influenza virus vaccines: NS1 truncation as an approach to virus attenuation","author":"Pica","year":"2011"},{"issue":"11","key":"10.1016\/j.vas.2026.100883_bib0150","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2165\/11209650-000000000-00000","article-title":"A\/H5N1 prepandemic influenza vaccine (whole virion, vero cell-derived, inactivated)[Vepacel\u00ae]","volume":"72","author":"Plosker","year":"2012","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0151","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3201\/eid3101.241343","article-title":"Systematic review of avian influenza virus infection and outcomes during pregnancy","volume":"31","author":"Purcell","year":"2025","journal-title":"Emerging Infectious Diseases"},{"issue":"50","key":"10.1016\/j.vas.2026.100883_bib0152","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1016\/j.vaccine.2005.07.098","article-title":"Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB\/c mice","volume":"23","author":"Pushko","year":"2005","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vas.2026.100883_bib0153","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1016\/j.vaccine.2007.02.059","article-title":"Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza","volume":"25","author":"Pushko","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vas.2026.100883_bib0154","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.12688\/f1000research.125878.2","article-title":"Avian influenza (H5N1) virus, epidemiology and its effects on backyard poultry in Indonesia: A review","volume":"11","author":"Rehman","year":"2023","journal-title":"F1000Research"},{"key":"10.1016\/j.vas.2026.100883_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-801238-3.95721-0","article-title":"Orthomyxoviruses: Structure of antigens","author":"Russell","year":"2016","journal-title":"Reference Module In Biomedical Sciences"},{"key":"10.1016\/j.vas.2026.100883_bib0156","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/82_2011_135","article-title":"Virus-like particles for antigen delivery at mucosal surfaces","author":"Schneider-Ohrum","year":"2011","journal-title":"Mucosal vaccines: Modern concepts, strategies, and challenges"},{"issue":"4","key":"10.1016\/j.vas.2026.100883_bib0157","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/infdis\/jiv091","article-title":"Immunogenicity and safety of an EB66 cell-culture-derived influenza A\/Indonesia\/5\/2005 (H5N1) AS03-adjuvanted vaccine: A phase 1 randomized trial","volume":"212","author":"Schuind","year":"2015","journal-title":"The Journal of Infectious Diseases"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0158","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2022.2155072","article-title":"Alarming situation of emerging H5 and H7 avian influenza and effective control strategies","volume":"12","author":"Shi","year":"2023","journal-title":"Emerging Microbes & Infections"},{"issue":"7","key":"10.1016\/j.vas.2026.100883_bib0159","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3390\/v17070927","article-title":"H5N1 Avian Influenza: A narrative review of scientific advances and global policy challenges","volume":"17","author":"Simancas-Racines","year":"2025","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.vas.2026.100883_bib0160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/vr.157.6.159","article-title":"Origin and evolution of highly pathogenic H5N1 avian influenza in Asia","volume":"157","author":"Sims","year":"2005","journal-title":"Veterinary Record"},{"issue":"32","key":"10.1016\/j.vas.2026.100883_bib0161","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1016\/j.vaccine.2015.06.043","article-title":"Systemic immune responses to an inactivated, whole H9N2 avian influenza virus vaccine using class B CpG oligonucleotides in chickens","volume":"33","author":"Singh","year":"2015","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.vas.2026.100883_bib0162","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1016\/j.vaccine.2016.08.009","article-title":"Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly (D, l-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens","volume":"34","author":"Singh","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vas.2026.100883_bib0163","unstructured":"\u015amietanka, K. and Z. Minta, Vaccination as an element of avian influenza control strategy. 2010."},{"issue":"11","key":"10.1016\/j.vas.2026.100883_bib0164","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2023.103078","article-title":"Evaluation of a self-amplifying mRNA reporter vaccine in explant models of broiler chickens","volume":"102","author":"Snoeck","year":"2023","journal-title":"Poultry Science"},{"issue":"11","key":"10.1016\/j.vas.2026.100883_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2023.103078","article-title":"Evaluation of a self-amplifying mRNA reporter vaccine in explant models of broiler chickens","volume":"102","author":"Snoeck","year":"2023","journal-title":"Poultry Science"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0166","doi-asserted-by":"crossref","DOI":"10.1080\/01652176.2025.2603307","article-title":"Influence of the administration route and dose on the expression and antibody responses of a reporter and avian influenza self-amplifying mRNA vaccine in poultry","volume":"46","author":"Snoeck","year":"2026","journal-title":"Veterinary Quarterly"},{"issue":"8","key":"10.1016\/j.vas.2026.100883_bib0167","first-page":"545","article-title":"Induction of heterologous immunity against current influenza serotypes by HA2 sub unit DNA vaccine","volume":"74","author":"Soleimani","year":"2016","journal-title":"Tehran University of Medical Sciences Journal"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0168","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12896-015-0195-z","article-title":"An avian influenza A (H7N9) virus vaccine candidate based on the fusion protein of hemagglutinin globular head and Salmonella typhimurium flagellin","volume":"15","author":"Song","year":"2015","journal-title":"BMC Biotechnology"},{"key":"10.1016\/j.vas.2026.100883_bib0169","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127438","article-title":"Lovastatin enhanced immune response to avian influenza vaccine in chickens and changed mRNA expression in the bursa of fabricius","volume":"61","author":"Song","year":"2025","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0170","article-title":"Avian influenza in low and middle-income countries (LMICs): Outbreaks, vaccination challenges and economic impact","volume":"44","author":"Subedi","year":"2024","journal-title":"Pakistan Veterinary Journal"},{"issue":"1 Suppl","key":"10.1016\/j.vas.2026.100883_bib0171","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1637\/7763-110706-REGR.1","article-title":"Understanding the complex pathobiology of high pathogenicity avian influenza viruses in birds","volume":"51","author":"Swayne","year":"2007","journal-title":"Avian Diseases"},{"issue":"7","key":"10.1016\/j.vas.2026.100883_bib0172","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1128\/JVI.00025-15","article-title":"Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia","volume":"89","author":"Swayne","year":"2015","journal-title":"Journal of Virology"},{"issue":"2","key":"10.1016\/j.vas.2026.100883_bib0173","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/03079457.2016.1257775","article-title":"Safe application of regionalization for trade in poultry and poultry products during highly pathogenic avian influenza outbreaks in the USA","volume":"46","author":"Swayne","year":"2017","journal-title":"Avian Pathology"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0174","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1600-065X.2008.00668.x","article-title":"Strategies and challenges for eliciting immunity against avian influenza virus in birds","volume":"225","author":"Swayne","year":"2008","journal-title":"Immunological Reviews"},{"issue":"5","key":"10.1016\/j.vas.2026.100883_bib0175","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines13050524","article-title":"Past, present, and future of viral vector vaccine platforms: A comprehensive review","volume":"13","author":"Tang","year":"2025","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.vas.2026.100883_bib0176","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1750-2659.2007.00016.x","article-title":"A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies","volume":"1","author":"Temperton","year":"2007","journal-title":"Influenza and Other Respiratory Viruses"},{"issue":"2","key":"10.1016\/j.vas.2026.100883_bib0177","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2146\/ajhp060181","article-title":"Avian influenza: A review","volume":"64","author":"Thomas","year":"2007","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"7","key":"10.1016\/j.vas.2026.100883_bib0178","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3201\/eid2907.221149","article-title":"Highly pathogenic avian influenza virus (H5N1) clade 2.3. 4.4 b introduced by wild birds, China, 2021","volume":"29","author":"Tian","year":"2023","journal-title":"Emerging Infectious Diseases"},{"issue":"15","key":"10.1016\/j.vas.2026.100883_bib0179","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1016\/j.vaccine.2006.09.047","article-title":"Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector","volume":"25","author":"Toro","year":"2007","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vas.2026.100883_bib0180","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1016\/j.vaccine.2009.08.056","article-title":"Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase","volume":"27","author":"Tsai","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vas.2026.100883_bib0181","doi-asserted-by":"crossref","DOI":"10.1016\/j.onehlt.2024.100714","article-title":"Re-evaluating efficacy of vaccines against highly pathogenic avian influenza virus in poultry: A systematic review and meta-analysis","volume":"18","author":"Tseng","year":"2024","journal-title":"One Health"},{"key":"10.1016\/j.vas.2026.100883_bib0182","doi-asserted-by":"crossref","unstructured":"Tsukamoto, K., Highly pathogenic avian influenza in Japan: Outbreaks, control measures, and roles of wild birds. 2012.","DOI":"10.20965\/jdr.2012.p0324"},{"issue":"9","key":"10.1016\/j.vas.2026.100883_bib0183","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1292\/jvms.25-0088","article-title":"Direct economic losses in farms and government compensation costs due to highly pathogenic avian influenza outbreaks in Japan during the 2022\u201323 season","volume":"87","author":"Ukita","year":"2025","journal-title":"Journal of Veterinary Medical Science"},{"issue":"2\u20133","key":"10.1016\/j.vas.2026.100883_bib0184","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0168-1656(99)00121-2","article-title":"Diva vaccines that reduce virus transmission","volume":"73","author":"van Oirschot","year":"1999","journal-title":"J Biotechnol"},{"issue":"4","key":"10.1016\/j.vas.2026.100883_bib0185","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.vaccine.2007.11.054","article-title":"Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice","volume":"26","author":"Wack","year":"2008","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vas.2026.100883_bib0186","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1074\/jbc.RA118.007008","article-title":"Structural and functional definition of a vulnerable site on the hemagglutinin of highly pathogenic avian influenza A virus H5N1","volume":"294","author":"Wang","year":"2019","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0187","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12951-025-03156-w","article-title":"Avian influenza mRNA vaccine encoding hemagglutinin provides complete protection against divergent H5N1 viruses in specific-pathogen-free chickens","volume":"23","author":"Wang","year":"2025","journal-title":"Journal of Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0188","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12951-025-03156-w","article-title":"Avian influenza mRNA vaccine encoding hemagglutinin provides complete protection against divergent H5N1 viruses in specific-pathogen-free chickens","volume":"23","author":"Wang","year":"2025","journal-title":"Journal of Nanobiotechnology"},{"issue":"19","key":"10.1016\/j.vas.2026.100883_bib0189","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1007\/s11434-012-5215-y","article-title":"Increased substitution rate in H5N1 avian influenza viruses during mass vaccination of poultry","volume":"57","author":"Wang","year":"2012","journal-title":"Chinese Science Bulletin"},{"issue":"10","key":"10.1016\/j.vas.2026.100883_bib0190","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1099\/vir.0.044032-0","article-title":"Antigenic analysis of highly pathogenic avian influenza virus H5N1 sublineages co-circulating in Egypt","volume":"93","author":"Watanabe","year":"2012","journal-title":"Journal of General Virology"},{"issue":"147","key":"10.1016\/j.vas.2026.100883_bib0191","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004273","article-title":"Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure","volume":"4","author":"Wei","year":"2012","journal-title":"Science Translational Medicine"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0192","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41541-017-0017-5","article-title":"H5N1 influenza vaccine induces a less robust neutralizing antibody response than seasonal trivalent and H7N9 influenza vaccines","volume":"2","author":"Wong","year":"2017","journal-title":"npj Vaccines"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0193","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/vaccines13010010","article-title":"Intranasal immunization with DNA vaccine HA-CCL19\/Polyethylenimine\/Chitosan composite provides immune protection against H7N9 infection","volume":"13","author":"Xiang","year":"2024","journal-title":"Vaccines"},{"issue":"12","key":"10.1016\/j.vas.2026.100883_bib0194","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1007\/s11427-017-9153-2","article-title":"Conserved peptides enhance immune efficiency of inactive vaccines against emerging avian influenza viruses in chicken","volume":"60","author":"Xiao","year":"2017","journal-title":"Science China Life Sciences"},{"issue":"7984","key":"10.1016\/j.vas.2026.100883_bib0195","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41586-023-06631-2","article-title":"The episodic resurgence of highly pathogenic avian influenza H5 virus","volume":"622","author":"Xie","year":"2023","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.vas.2026.100883_bib0196","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3390\/v15081694","article-title":"Multiple vaccines and strategies for pandemic preparedness of Avian Influenza Virus","volume":"15","author":"Xu","year":"2023","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.vas.2026.100883_bib0197","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1128\/JVI.02162-09","article-title":"Structure, receptor binding, and antigenicity of influenza virus hemagglutinins from the 1957 H2N2 pandemic","volume":"84","author":"Xu","year":"2010","journal-title":"Journal of virology"},{"key":"10.1016\/j.vas.2026.100883_bib0198","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126286","article-title":"An immune-enhanced multivalent DNA nanovaccine to prevent H7 and H9 avian influenza virus in mice","volume":"251","author":"Xu","year":"2023","journal-title":"International Journal of Biological Macromolecules"},{"issue":"10","key":"10.1016\/j.vas.2026.100883_bib0199","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2023.102925","article-title":"Enhance immune response to H9 AIV DNA vaccine based on polygene expression and DGL nanoparticle encapsulation","volume":"102","author":"Xu","year":"2023","journal-title":"Poultry Science"},{"issue":"18","key":"10.1016\/j.vas.2026.100883_bib0200","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1016\/j.vaccine.2023.03.049","article-title":"A new H9 influenza virus mRNA vaccine elicits robust protective immunity against infection","volume":"41","author":"Xu","year":"2023","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vas.2026.100883_bib0201","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2023.102925","article-title":"Enhance immune response to H9 AIV DNA vaccine based on polygene expression and DGL nanoparticle encapsulation","volume":"102","author":"Xu","year":"2023","journal-title":"Poult Sci"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0202","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/viro.1999.9820","article-title":"Genetic characterization of the pathogenic influenza A\/Goose\/Guangdong\/1\/96 (H5N1) virus: Similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong","volume":"261","author":"Xu","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vas.2026.100883_bib0203","article-title":"Influenza virus-like particles containing HA, NA, and M1 induced protection in chickens against a lethal challenge with the highly pathogenic H5N1 avian influenza virus","volume":"4","author":"Yanase","year":"2013","journal-title":"Journal of Vaccines & Vaccination"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0204","doi-asserted-by":"crossref","DOI":"10.1038\/srep39665","article-title":"Cross-protective efficacy of dendritic cells targeting conserved influenza virus antigen expressed by Lactobacillus plantarum","volume":"6","author":"Yang","year":"2016","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1016\/j.vas.2026.100883_bib0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2023.102662","article-title":"Recombinant hemagglutinin protein and DNA-RNA-combined nucleic acid vaccines harbored by yeast elicit protective immunity against H9N2 avian influenza infection","volume":"102","author":"Zhang","year":"2023","journal-title":"Poultry Science"},{"issue":"11","key":"10.1016\/j.vas.2026.100883_bib0206","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.3390\/v4112711","article-title":"Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines","volume":"4","author":"Zhang","year":"2012","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0207","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12257-022-0107-8","article-title":"Virus-like particles as antiviral vaccine: Mechanism, design, and application","volume":"28","author":"Zhang","year":"2023","journal-title":"Biotechnology and Bioprocess Engineering"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0208","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1743-422X-9-97","article-title":"The new temperature-sensitive mutation PA-F35S for developing recombinant avian live attenuated H5N1 influenza vaccine","volume":"9","author":"Zhang","year":"2012","journal-title":"Virology Journal"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0209","first-page":"160","article-title":"Characterization of a monoclonal antibody against the hemagglutinin stem of H7N9 subtype avian influenza virus","volume":"38","author":"Zhao","year":"2022","journal-title":"Sheng wu Gong Cheng xue bao= Chinese Journal of Biotechnology"},{"key":"10.1016\/j.vas.2026.100883_bib0210","article-title":"Genetic evolution and molecular characteristics of avian influenza viruses in Jining from 2018 to 2023","volume":"16","author":"Zhao","year":"2025","journal-title":"Frontiers in Microbiology"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0211","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2284301","article-title":"Recombinant duck enteritis virus bearing the hemagglutinin genes of H5 and H7 influenza viruses is an ideal multivalent live vaccine in ducks","volume":"13","author":"Zhao","year":"2024","journal-title":"Emerging Microbes and Infections"},{"issue":"12","key":"10.1016\/j.vas.2026.100883_bib0212","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.3390\/v4123589","article-title":"Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza","volume":"4","author":"Zheng","year":"2012","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.vas.2026.100883_bib0213","doi-asserted-by":"crossref","first-page":"101","DOI":"10.36233\/10.36233\/0507-4088-213","article-title":"Avian flu:\u00abfor whom the bell tolls\u00bb?","volume":"69","author":"Zhirnov","year":"2024","journal-title":"Problems of Virology"},{"issue":"2","key":"10.1016\/j.vas.2026.100883_bib0214","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11262-012-0849-z","article-title":"Interaction of avian influenza virus NS1 protein and nucleolar and coiled-body phosphoprotein 1","volume":"46","author":"Zhu","year":"2013","journal-title":"Virus Genes"},{"issue":"1","key":"10.1016\/j.vas.2026.100883_bib0215","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/v16010163","article-title":"The Chinese hamster ovary cell-based H9 HA subunit avian influenza vaccine provides complete protection against the H9N2 virus challenge in chickens","volume":"16","author":"Zhu","year":"2024","journal-title":"Viruses"}],"container-title":["Veterinary and Animal Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451943X26003121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451943X26003121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:33:57Z","timestamp":1793648037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451943X26003121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":215,"alternative-id":["S2451943X26003121"],"URL":"https:\/\/doi.org\/10.1016\/j.vas.2026.100883","relation":{},"ISSN":["2451-943X"],"issn-type":[{"value":"2451-943X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances and challenges in avian influenza vaccines: From conventional approaches to next-generation strategies","name":"articletitle","label":"Article Title"},{"value":"Veterinary and Animal Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vas.2026.100883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100883"}}